Short Term Trading Week Starting: 5th Sept, page-448

STTCOMP 1AD, FA Long - Bio
(ASX: 1AD – AdAlta Limited)
SP: 22c
MC: $22 Million
Cash $10M (AUD)
Shares: 100M, with over 50M in escrow for 6-24 months. 70% owned by cornerstone investors, including Platinum Asset Management (8%).

AdAlta has an advanced lead fibrosis drug candidate AD-114 with significant pre-clinical validation. Recently listed to accelerate the development of its drug, which has numerous advantages over the existing treatments. Big global market of more than 4.2b.

An investor presentation was released today, which strongly suggests the end game is to be snapped up by big pharma. The company will be presenting to brokers next week, which may prove a price catalyst. Thus far it has been quite illiquid, and there is not ONE post on the HC forum!! I know bio is not so much in favour at the moment, but the presentation is well-worth a read IMO and this could be one diamond in the rough.

First ever tip, go easy on me!